Does OSIMERTINIB Cause Onycholysis? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Onycholysis have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.0% of all adverse event reports for OSIMERTINIB.
9
Reports of Onycholysis with OSIMERTINIB
0.0%
of all OSIMERTINIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Onycholysis From OSIMERTINIB?
Of the 9 reports, 1 (11.1%) resulted in death, 1 (11.1%) required hospitalization.
Is Onycholysis Listed in the Official Label?
Yes, Onycholysis is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Onycholysis?
PACLITAXEL (173)
DOCETAXEL (130)
TRASTUZUMAB (109)
SECUKINUMAB (82)
ADALIMUMAB (77)
CAPECITABINE (73)
METHOTREXATE (67)
PERTUZUMAB (55)
ERDAFITINIB (44)
CARBOPLATIN (42)
Which OSIMERTINIB Alternatives Have Lower Onycholysis Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN